Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data.
By T. V. Van Boeckel, Sumanth Gandra, A. Ashok, Q. Caudron, Bryan T. Grenfell, Simon A. Levin, Ramanan Laxminarayan. Lancet. Infectious Diseases (Print), 2014
1,988 citations recorded by the source corpus.
Subfields: Applied Microbiology and Biotechnology, Economics and Econometrics, Pollution
View Paper: https://www.semanticscholar.org/paper/c30c55a16cdcf1bb6ee4e2bcc6fbcf9d9e40cd65
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Applied Microbiology and Biotechnology
In Economics and Econometrics
- Ramanan Laxminarayan
- Suraj Pant
- E. Martínez
- Eili Y. Klein
- H. Goossens
- F. Bux
- Martin J. Blaser
- Sumanth Gandra
In Pollution
Citations in the corpus
- Review article: the global emergence of Helicobacter pylori antibiotic resistance (2015, background): “This overall increase in antibiotic consumption also includes a global increase in macrolide consumption by approximately 20% over this time period.(217) As antibiotic resistance has been correlated with antibiotic usage, the continual increase in usage of broad-spectrum antibiotics in recent years ”
- Global increase and geographic convergence in antibiotic consumption between 2000 and 2015 (2018, background): “The largest prior study reported that antibiotic consumption increased 36% between 2000 and 2010 in 71 countries (15).”
- Removal of antibiotic resistance genes (ARGs) in various wastewater treatment processes: An overview (2020, background): “For several decades, the global consumption of antibiotics has increased due to the increase of population and demands (Liu et al., 2017; Van Boeckel et al., 2017).”
- Status of pathogens, antibiotic resistance genes and antibiotic residues in wastewater treatment systems (2017, background): “Seventy-six percent of the general increase in antibiotic consumption globally between 2000 and 2010 was inferable to BRICS countries, including, Brazil, Russia, India, China, and South Africa (Van Boeckel et al. 2014a, b).”
- Antibiotic Use in Poultry Production and Its Effects on Bacterial Resistance (2018, background): “developments, it is currently estimated that over 60% of all antibiotics produced are used in livestock production, including poultry [6, 31].”
- Pharmaceuticals in the environment—Global occurrences and perspectives (2016, background): “A growing world population, increasing investment in the health-care sector, advances in research and development, pervasive global market availability, and aging societies in industrialized countries have led to a significant increase in the consumption of pharmaceuticals in the last few decades [1”
- Activated carbons from agricultural byproducts (pine tree and coconut shell), coal, and carbon nanotubes as adsorbents for removal of sulfamethoxazole from spiked aqueous solutions: Kinetic and thermodynamic studies (2015, background): “Antibiotics are used worldwide in great amounts, and their an annual consumption was estimated to be 1169–109908 g ha−1 year−1 (de la Cruz et al., 2014; Van Boeckel et al. 2014).”
- Antibiotic use and its consequences for the normal microbiome (2016, background): “In 2010, the top seven antibiotic classes were consumed in an estimated 70 billion individual doses, which equates to about 10 pills, capsules, or teaspoons for every man, woman, and child on earth (2), an annual rate that appears to be rising.”
- Dissemination of Antimicrobial Resistance in Microbial Ecosystems through Horizontal Gene Transfer (2016, background): “In their analysis, Van Boeckel et al. showed that global human antibiotic consumption amounted to 54,083,964,813 standard units (pills, capsules, or ampoules) in 2000 and had increased by 36% to 73,620,748,816 standard units by 2010 (Van Boeckel et al., 2014).”